Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Leena Yeolekar"'
Autor:
Nachiket Shembekar, Vamsee V Aditya Mallajosyula, Arpita Mishra, Leena Yeolekar, Rajeev Dhere, Subhash Kapre, Raghavan Varadarajan, Satish Kumar Gupta
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e55516 (2013)
Influenza virus evades host immunity through antigenic drift and shift, and continues to circulate in the human population causing periodic outbreaks including the recent 2009 pandemic. A large segment of the population was potentially susceptible to
Externí odkaz:
https://doaj.org/article/4be2607e36af423d946ff0f07efd9e8a
Autor:
Rajeev M. Dhere, Francesco Berlanda-Scorza, Koert J. Stittelaar, Geert van Amerongen, Milan Ganguly, Kate Guilfoyle, Leena Yeolekar, Parikshit Tyagi, Kutub Mahmood
Publikováno v:
Vaccine. 38:6280-6290
During a pandemic, the availability of specific pathogen free chicken eggs is a major bottleneck for up-scaling response to the demand for influenza vaccine. This has led us to explore the use of Madin-Darby Canine Kidney (MDCK) cells for the manufac
Autor:
Francesco Berlanda Scorza, Yashodhan Anaspure, Rajeev M. Dhere, Parikshit Tyagi, Milan Ganguly, Kutub Mahmood, Umesh Sagar, Leena Yeolekar, Nilesh B. Ingle, Swapnil Narale, Sham Tupe, Kuntinath Wadkar
Publikováno v:
Vaccine. 38(52)
Cell culture based live attenuated influenza vaccines (LAIV) as an alternative to egg-based LAIV have been explored because of lack of easy access to SPF eggs for large scale production. In this study, feasibility of MDCK platform was assessed by inc
Publikováno v:
Vaccine
Highlights • LAIV has been used in Russia for decades. • Russian LAIV consistently provides superior effective protection against influenza. • It was incorporated into the WHO global pandemic influenza action plan. • A number of Russian LAIVs
Autor:
Nilesh B. Ingle, Kutub Mahmood, Rajeev M. Dhere, Milan Ganguly, Francesco Berlanda Scorza, Parikshit Tyagi, Koert J. Stittelaar, Leon de Waal, Leena Yeolekar
Publikováno v:
Vaccine. 36(46)
A ferret challenge study was conducted to address the efficacy of the egg-based and Madin-Darby canine kidney (MDCK)-based live attenuated influenza vaccine (LAIV) strains. Vaccines derived as 6:2 reassortants from the A/Leningrad/134/17/57 master do
Autor:
Julian Hickling, Nancy J. Cox, Linda C. Lambert, Rebecca Jones, Leena Yeolekar, Larisa Rudenko, Joachim Hombach, Justin R. Ortiz, Guus F. Rimmelzwaan, John W. Boslego, James S. Robertson
Publikováno v:
Vaccine
Vaccine, 33(48), 6503-6510. Elsevier
Vaccine, 33(48), 6503-6510. Elsevier
On 5-7 May 2014, the World Health Organization (WHO) convened the second integrated meeting on "influenza vaccines that induce broadly protective and long-lasting immune responses". Around 100 invited experts from academia, the vaccine industry, rese
Autor:
Ravi Menon, Leena Yeolekar, Vivek Vaidya, Rajeev M. Dhere, Prajakt Barde, Parikshit Tyagi, Milan Ganguly, Suresh Jadhav, Prasad S. Kulkarni
Publikováno v:
Vaccine. 29:A16-A21
In the event of a highly pathogenic influenza pandemic, the Indian subcontinent would need 1.2 billion doses of vaccine to immunize its entire population, double if two doses were required to assure immunity. Serum Institute of India Limited (SII) th
Publikováno v:
Procedia in Vaccinology, 2(2):166-171
It is predicted that in case of an influenza pandemic, there will be a significant gap between potentially available vaccine supply and international demand. This paved the way for a WHO Global Pandemic Influenza Action Plan (GAP) aiming at increasin
Autor:
Satish K. Gupta, Rajeev M. Dhere, Vamsee Mallajosyula, Nachiket Shembekar, Leena Yeolekar, Raghavan Varadarajan, Arpita Mishra, Subhash V. Kapre
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e55516 (2013)
PLoS ONE
PLoS ONE
Influenza virus evades host immunity through antigenic drift and shift, and continues to circulate in the human population causing periodic outbreaks including the recent 2009 pandemic. A large segment of the population was potentially susceptible to
Autor:
Rajeev M. Dhere, Leena Yeolekar
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 40(2)
Live attenuated influenza vaccines (LAIVs) targeting seasonal influenza are produced in embryonated eggs and formulated as a trivalent preparation of three live attenuated vaccine strains, one A(H1N1) strain, one A(H3N2) strain and one type B strain.